相关实验视频

Updated: May 13, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

对转化为渐进性多发性硬化症的现实数据预测者的系统审查和元分析

Luis Rafael Solís-Tarazona¹, Maria Molina-Castaño¹, Lucas Barea-Moya¹

¹Research Group in Immunotherapy and Biomodels for Autoimmunity, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Multiple sclerosis and related disorders

|August 21, 2025

概括

预测多发性硬化症 (MS) 的进展有助于GFAP和NfL等液体生物标志物,以及脊髓损伤等MRI发现. 这些标志物提供了关于疾病进展的强有力的洞察力.

科学领域:

神经学
生物标志物发现
医学成像

背景情况:

使用液体生物标志物,神经成像和临床评估可以改善转化为二次进展性多发性硬化症 (SPMS).
确定可靠的MS进展预测因子对于患者的治疗至关重要.

研究的目的:

进行系统的文献审查,以确定多发性硬化症 (MS) 进展的强有力的现实预测因素.
综合各种生物标志物和成像技术在预测多发性硬化症进展方面的证据.

主要方法:

使用EMBASE数据库对包括20338名多发性硬化患者在内的64项研究进行了系统性文献审查.
进行了p值元分析和临界点分析,以评估与MS进展和扩展残疾状态量表 (EDSS) 的关联.

主要成果:

脑脊液 (CSF) 生物标志物GFAP和CHI3L1以及血清生物标志物NfL与MS进展有很强的关联.
脊髓损伤和铁边损伤在MRI上被确定为显著的放射学预测因素.
临床评估显示与并发性EDSS相关,但对未来进展的预测能力有限.

结论:

流体生物标志物 (CSF GFAP,CHI3L1,血清NfL) 和特定的MRI发现 (脊髓和铁边损伤) 是MS进展的一致预测因素.
需要在现实世界MS数据集中进行协调和可访问的结果测量,以提高预测准确度.

关键词:

可访问性生物标志物大脑脊髓液扩大残疾人身份表多发性硬化症神经成像进展情况

更多相关视频

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

相关概念视频

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...